PubRank

A Global Study to Assess the Effects of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer (ARCTIC)

Clinical Trial ID NCT02352948

PubWeight™ 11.95‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02352948

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antibodies to watch in 2016. MAbs 2015 1.17
2 Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy. J Hematol Oncol 2016 1.12
3 Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade. J Clin Invest 2015 0.98
4 Checkpoint inhibitors in lung cancer: latest developments and clinical potential. Ther Adv Med Oncol 2016 0.96
5 Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications. Front Immunol 2015 0.92
6 Current progress in immunotherapy for pancreatic cancer. Cancer Lett 2015 0.83
7 Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential. Ther Adv Med Oncol 2016 0.81
8 Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role. Transl Lung Cancer Res 2015 0.80
9 PD-1/PD-L1 blockades in non-small-cell lung cancer therapy. Onco Targets Ther 2016 0.78
10 Trends and advances in tumor immunology and lung cancer immunotherapy. J Exp Clin Cancer Res 2016 0.78
11 Immunotherapy in non-small cell lung cancer: the clinical impact of immune response and targeting. Ann Transl Med 2016 0.77
12 Immunotherapy for non-small cell lung cancer: current concepts and clinical trials. Eur J Cardiothorac Surg 2015 0.77
13 Lung cancer in 2015: Bypassing checkpoints, overcoming resistance, and honing in on new targets. Nat Rev Clin Oncol 2015 0.76
14 Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment. Onco Targets Ther 2016 0.75
Next 100